Infectious Disease· Topic 7.17 Specific causative organisms· 7.17.30

Anthrax

Anthrax is caused by Bacillus anthracis spores acquired by inhalation, cutaneous inoculation, or ingestion, with cutaneous disease most common and inhalational disease most lethal. Systemic disease is treated with ciprofloxacin or doxycycline plus additional agents and antitoxin for 60 days, and any inhalational case is a bioterrorism sentinel event requiring immediate public health notification.

7 min read7 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Bacillus anthracis infection: a spore-forming, gram-positive, "box-car"-shaped bacillus that produces disease through three clinical forms: cutaneous (most common), inhalational (most deadly), and gastrointestinal.

  • Epidemiology

    Occupational cluster pattern: naturally occurring cases cluster among individuals handling livestock or animal products (wool-sorters, tanners, farmers, veterinarians); a temporal or demographic…

  • Risk factors

    Direct animal or animal-product contact: handling infected livestock, hides, wool, hair, or bone meal.

  • Pathophysiology

    Spore germination at the site of entry: B.

  • Clinical features

    Cutaneous anthrax (most common): begins 1-7 days after skin exposure as a painless-to-pruritic papule that enlarges into an ulcer with a surrounding edematous halo and a round, raised, regular…

  • Differential diagnosis

    Plague (Yersinia pestis): fulminant pneumonia and sepsis with buboes; incubation is shorter (1-6 days) and gram-negative bipolar-staining coccobacilli distinguish it on culture.

  • Diagnosis

    Culture or PCR establishes the diagnosis: confirmatory diagnosis is made by culture or polymerase chain reaction (PCR) of blood, tissue, or fluid samples; any case of inhalational anthrax should be…

  • Management

    First, start combination antimicrobial therapy immediately for suspected systemic (inhalational, gastrointestinal, or meningeal) anthrax: ciprofloxacin 400 mg IV every 8-12 hr or doxycycline 100 mg…

  • Complications

    Meningitis: occurs in up to 50% of systemic disease and carries a high mortality; hemorrhagic meningitis is a classic finding at autopsy in fatal cases.

  • Prognosis

    Inhalational anthrax has the highest mortality of the three clinical forms, particularly when treatment is delayed until systemic symptoms and radiographic mediastinal widening appear.

  • Prevention

    Anthrax vaccine absorbed (AVA) postexposure, three subcutaneous doses at 0, 2, and 4 weeks, started within 10 days of a known or suspected exposure, given together with 60 days of ciprofloxacin or…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.